4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001387131-20-011272
10% owner bought 1,100,000 shares at $23.00 ($25,300,000)
- 10% owner acquired 2,837,914 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP 10% owner | 2020-12-15 | Conversion | +2,004,581 | 2,004,581 | I | ||
| VIKING GLOBAL INVESTORS LP 10% owner | 2020-12-15 | Conversion | +833,333 | 2,837,914 | I | ||
| VIKING GLOBAL INVESTORS LP 10% owner | 2020-12-15 | Purchase | +1,100,000 | $23.00 | $25,300,000 | 3,937,914 | I |
| Derivatives | |||||||
| VIKING GLOBAL INVESTORS LP 10% owner | 2020-12-15 | Conversion · Series B Redeemable Convertible Preferred Stock | −2,004,581 | 0 | I | ||
| VIKING GLOBAL INVESTORS LP 10% owner | 2020-12-15 | Conversion · Series C Redeemable Convertible Preferred Stock | −833,333 | 0 | I | ||
| Open-market purchases · 1,100,000 sh · avg $23.00 · $25,300,000 | |||||||
Loading xslF345X03/fdmt-form4_121520.xml…